Decision Assist

Prostate cancer test

Introduction

The purpose of this tool is to help you decide whether or not to have testing for prostate-specific antigen. When making a decision like this, you must balance:

This tool is not a substitute for professional medical care and advice. Work with your doctor to help you make this decision. A second opinion from another doctor may be valuable. There is usually no exact “right” or “wrong” answer.

Your physician may make certain recommendations to you. However, the final decision about whether to have this test rests with you.

What is the test?

The PSA test measures the amount of PSA (prostate-specific antigen) in the blood.

A high PSA level has been linked to an increased chance of having prostate cancer, but it does not mean that the person definitely has cancer. Several conditions besides cancer can cause the PSA level to rise. These include a urinary tract infection, benign prostatic hypertrophy (BPH -- an enlarged prostate), and prostatitis (an infection in the prostate).

PSA is a glycoprotein (a protein with a sugar attached) found in prostate cells. It can be detected at a low level in the blood of all adult men.

PSA blood test

Only a biopsy can detect prostate cancer, usually after PSA testing or a digital rectal exam (DRE), suggests that cancer or an enlarged prostate may be present.

Prostate cancer
Click the icon to see an illustration detailing prostate cancer.

Key points

How much time this decision tool will take

What this tool will provide


Review Date: 12/31/2010
Reviewed By: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine. Previously reviewed by David R. Knowles MD, Advanced Urologic Surgeons, Mount Vernon, IL. Review provided by VeriMed Healthcare Network (10/6/2008).

References:
  • Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level less than or equal to 4.0 ng per milliliter. The New England Journal of Medicine. 2004;350(22):2239–2246.
  • Barry MJ. Prostate-specific-antigen testing for early diagnosis of prostate cancer. New England Journal of Medicine. 2001;344:1373-1377.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com